Spain · Delayed Price · Currency is EUR BME:CCEP Statistics
Total Valuation
BME:CCEP has a market cap or net worth of EUR 40.76 billion. The enterprise value is 50.97 billion.
| Market Cap | 40.76B |
| Enterprise Value | 50.97B |
Important Dates
The last earnings date was Tuesday, February 17, 2026.
| Earnings Date | Feb 17, 2026 |
| Ex-Dividend Date | Nov 13, 2025 |
Share Statistics
| Current Share Class | 447.94M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.09% |
| Shares Change (QoQ) | -1.31% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 35.73% |
| Float | 202.17M |
Valuation Ratios
The trailing PE ratio is 20.99 and the forward PE ratio is 20.42.
| PE Ratio | 20.99 |
| Forward PE | 20.42 |
| PS Ratio | 1.95 |
| PB Ratio | 4.91 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.50 |
| P/OCF Ratio | 13.80 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.13, with an EV/FCF ratio of 23.14.
| EV / Earnings | 26.24 |
| EV / Sales | 2.44 |
| EV / EBITDA | 14.13 |
| EV / EBIT | 18.98 |
| EV / FCF | 23.14 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.29.
| Current Ratio | 0.80 |
| Quick Ratio | 0.50 |
| Debt / Equity | 1.29 |
| Debt / EBITDA | 2.96 |
| Debt / FCF | 4.85 |
| Interest Coverage | 8.77 |
Financial Efficiency
Return on equity (ROE) is 22.89% and return on invested capital (ROIC) is 11.47%.
| Return on Equity (ROE) | 22.89% |
| Return on Assets (ROA) | 5.50% |
| Return on Invested Capital (ROIC) | 11.47% |
| Return on Capital Employed (ROCE) | 12.05% |
| Weighted Average Cost of Capital (WACC) | 5.25% |
| Revenue Per Employee | 509,780 |
| Profits Per Employee | 47,366 |
| Employee Count | 41,000 |
| Asset Turnover | 0.69 |
| Inventory Turnover | 8.54 |
Taxes
In the past 12 months, BME:CCEP has paid 590.00 million in taxes.
| Income Tax | 590.00M |
| Effective Tax Rate | 22.97% |
Stock Price Statistics
The stock price has increased by +9.82% in the last 52 weeks. The beta is 0.33, so BME:CCEP's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | +9.82% |
| 50-Day Moving Average | 79.77 |
| 200-Day Moving Average | 79.06 |
| Relative Strength Index (RSI) | 82.52 |
| Average Volume (20 Days) | 5,195 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CCEP had revenue of EUR 20.90 billion and earned 1.94 billion in profits. Earnings per share was 4.26.
| Revenue | 20.90B |
| Gross Profit | 7.44B |
| Operating Income | 2.69B |
| Pretax Income | 2.57B |
| Net Income | 1.94B |
| EBITDA | 3.61B |
| EBIT | 2.69B |
| Earnings Per Share (EPS) | 4.26 |
Balance Sheet
The company has 957.00 million in cash and 10.69 billion in debt, with a net cash position of -9.74 billion.
| Cash & Cash Equivalents | 957.00M |
| Total Debt | 10.69B |
| Net Cash | -9.74B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.30B |
| Book Value Per Share | 17.46 |
| Working Capital | -1.51B |
Cash Flow
In the last 12 months, operating cash flow was 2.95 billion and capital expenditures -750.00 million, giving a free cash flow of 2.20 billion.
| Operating Cash Flow | 2.95B |
| Capital Expenditures | -750.00M |
| Free Cash Flow | 2.20B |
| FCF Per Share | n/a |
Margins
Gross margin is 35.58%, with operating and profit margins of 12.85% and 9.29%.
| Gross Margin | 35.58% |
| Operating Margin | 12.85% |
| Pretax Margin | 12.29% |
| Profit Margin | 9.29% |
| EBITDA Margin | 17.26% |
| EBIT Margin | 12.85% |
| FCF Margin | 10.54% |
Dividends & Yields
This stock pays an annual dividend of 2.04, which amounts to a dividend yield of 2.23%.
| Dividend Per Share | 2.04 |
| Dividend Yield | 2.23% |
| Dividend Growth (YoY) | 1.92% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 47.90% |
| Buyback Yield | 1.09% |
| Shareholder Yield | 3.36% |
| Earnings Yield | 4.76% |
| FCF Yield | 5.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CCEP has an Altman Z-Score of 2.34 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.34 |
| Piotroski F-Score | 6 |